Health Care
Companies operating within the Health Care industry, ranked by market capitalization.
| Ticker | Exchange | Company Name | Last Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| INSM | NASDAQ | Insmed | $135.66 | +0.47% | 2M | $28.8B |
| RPRX | NASDAQ | Royalty Pharma plc | $50.31 | +1.66% | 3M | $28.57B |
| BIIB | NASDAQ | Biogen | $191.13 | -1.67% | 1M | $28.53B |
| RVMD | NASDAQ | Revolution Medicines | $139.53 | -0.73% | 4M | $27.17B |
| GEHC | NASDAQ | GE HealthCare Technologies | $60.14 | +1.10% | 8M | $27.11B |
| NTRA | NASDAQ | Natera | $198.91 | +2.13% | 1M | $26.88B |
| IQV | NYSE | IQVIA Holdings | $157.91 | +0.80% | 1M | $26.63B |
| CNC | NYSE | Centene | $53.63 | -0.65% | 11M | $26.55B |
| VEEV | NYSE | Veeva Systems | $154.22 | -2.53% | 2M | $26.01B |
| MTD | NYSE | MettlerToledo International | $1,250.22 | +0.81% | 123K | $25.33B |
| UTHR | NASDAQ | United Therapeutics | $575.60 | +0.79% | 285K | $24.59B |
| BNTX | NASDAQ | BioNTech SE | $104.40 | +2.79% | 633K | $24.42B |
| DXCM | NASDAQ | Dexcom | $58.04 | +0.83% | 4M | $22.45B |
| LH | NYSE | Laboratory Of America Holdings | $258.72 | +0.61% | 779K | $21.32B |
| WST | NYSE | West Pharmaceutical Services | $294.92 | -0.15% | 1M | $21.27B |
| STE | NYSE | Steris Plc | $213.61 | +0.45% | 532K | $20.87B |
| DGX | NYSE | Quest Diagnostics | $191.80 | +1.31% | 1M | $20.8B |
| INCY | NASDAQ | yte | $98.57 | -0.53% | 2M | $19.72B |
| ROIV | NASDAQ | Roivant Sciences | $28.17 | +2.36% | 5M | $19.14B |
| ILMN | NASDAQ | Illumina | $123.83 | +2.87% | 1M | $18.39B |
| MRNA | NASDAQ | Moderna | $47.72 | +4.37% | 5M | $17.86B |
| WAT | NYSE | Waters | $299.04 | +2.36% | 1M | $17.39B |
| VTRS | NASDAQ | Viatris | $15.05 | +0.50% | 11M | $17.24B |
| GMAB | OMX NORDIC EXCHANGE COPENHAGEN A/S | Genmab | $26.54 | +1.65% | 1M | $16.76B |
| ZBH | NYSE | Zimmer Biomet Holdings | $81.12 | +1.31% | 4M | $15.87B |
| THC | NYSE | Tenet Healthcare | $176.33 | -2.09% | 2M | $15.83B |
| SMMT | NASDAQ | Summit Therapeutics | $21.85 | +4.90% | 4M | $15.51B |
| RGC | NASDAQ | Regencell Bioscience Holdings | $29.78 | +2.87% | 91K | $14.32B |
| BBIO | NASDAQ | BridgeBio Pharma | $71.50 | +0.79% | 5M | $13.67B |
| ASND | NASDAQ | Ascendis Pharma A/S | $224.06 | +1.72% | 1M | $13.46B |
| ASND | NASDAQ | Ascendis Pharma A/S | $222.44 | +0.98% | 1M | $13.46B |
| SNN | LONDON STOCK EXCHANGE | Smith & Nephew plc | $30.65 | +0.89% | 1M | $13.33B |
| NBIX | NASDAQ | Neurocrine Biosciences | $132.48 | +0.95% | 1M | $13.08B |
| FMS | XETRA | Fresenius Medical Care AG & Co. KGaA | $22.34 | +0.81% | 407K | $12.85B |
| ALGN | NASDAQ | Align Technology | $170.13 | -4.64% | 1M | $12.8B |
| PEN | NYSE | Penumbra | $324.55 | -0.08% | 514K | $12.72B |
| JAZZ | NASDAQ | Jazz Pharmaceuticals plc | $202.14 | +1.11% | 861K | $12.15B |
| IONS | NASDAQ | Ionis Pharmaceuticals | $75.63 | +1.07% | 2M | $12.12B |
| COO | NASDAQ | Cooper Companies | $62.08 | +1.20% | 2M | $12.02B |
| EXEL | NASDAQ | Exelixis | $44.96 | +0.60% | 2M | $11.98B |
| MDGL | NASDAQ | Madrigal Pharmaceuticals | $515.50 | -0.59% | 225K | $11.78B |
| GMED | NYSE | Globus Medical | $88.98 | +1.36% | 748K | $11.75B |
| MEDP | NASDAQ | Medpace Holdings | $415.02 | +0.35% | 886K | $11.74B |
| SOLV | NYSE | Solventum | $65.82 | -1.01% | 917K | $11.53B |
| PODD | NASDAQ | Insulet | $166.81 | +4.24% | 2M | $11.26B |
| ELAN | NYSE | Elanco Animal Health | $22.05 | +1.15% | 5M | $10.83B |
| ENSG | NASDAQ | Ensign Group | $183.92 | -1.33% | 389K | $10.8B |
| DVA | NYSE | DaVita | $151.05 | -0.62% | 608K | $10.64B |
| GH | NASDAQ | Guardant Health | $84.33 | +1.10% | 2M | $10.51B |
| UHS | NYSE | Universal Health Services | $168.16 | +0.11% | 1M | $10.5B |